The COVID-19 pandemic has pushed contract management, procurement, and sourcing professionals into uncharted waters regarding their business operations. Organizations need to quickly find ways to cut contract-related costs and save money during times of crisis such as pandemics, economic recessions, company acquisitions/mergers, and downturns in business. CobbleStone Software’s Contract Insight can help. Here’s how.
As Coronavirus (COVID-19) is now a global pandemic - with the United States presenting the most significant number of cases - I am reminded of current and past experiences implementing contract management software to help organizations with clinical trials and drug development tracking. Organizations in the medical field, healthcare, pharmaceuticals, biopharmaceuticals, and other related industries need to effectively manage drug development contracts and obligations, clinical trials, manufacturing of medicine, and key opinion leaders globally. CobbleStone’s leading enterprise contract lifecycle management software provides the solution to these challenges.
Whether it is due to the increasing digitization of the modern workplace or because of an unforeseen circumstance, working remotely is becoming progressively more commonplace. As such, it is important that professionals in a myriad of industries are supported with sufficient tools to keep contract management, procurement, and sourcing operations running smoothly. IntelliSign electronic signatures with CobbleStone’s Contract Insight® equip organizations with a configurable, streamlined, and user-friendly document collaboration and signing process both in-office and on the go. This article will explain how.